🔗 Share this article

Chancellor Reeves has revealed she is preparing "targeted measures to deal with household expense pressures" in the upcoming financial statement.

In comments to media outlets, she stated that curbing price rises is a joint responsibility of both the government and the Bank of England.

The UK's inflation rate is forecast to be the most elevated among the G7 developed nations this calendar year and the following year.

Possible Energy Bill Interventions

Reports indicate the government could take action to lower energy bills, such as by reducing the current 5% level of VAT charged on energy supplies.

Another approach is to reduce some of the policy costs presently added to household expenses.

Budgetary Constraints and Expert Predictions

The government will obtain the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for such measures.

The view from the majority of economists is that Reeves will have to announce tax rises or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Previously on Thursday, analysis suggested there was a twenty-two billion pound shortfall for the chancellor to address, which is at the lower end of forecasts.

"It is a collective job between the central bank and the government to further reduce some of the drivers of inflation," the Chancellor told the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and International Issues

While much of the attention has been on likely tax rises, the chancellor said the most recent information from the OBR had not changed her commitment to campaign commitments not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "uncertain world" with rising geopolitical and commercial issues for the Budget revenue measures, likely to be focused on those "wealthiest."

Global Economic Disputes

Referring to worries about the United Kingdom's economic relations with the Asian nation she said: "Our national security invariably are paramount."

Last week's announcement by China to increase trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader the US President to suggest an further 100% import tax on imports from the Asian country, raising the risk of an full-scale commercial conflict between the two global powers.

The American finance chief described the Chinese move "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the American proposal to join its conflict with the Asian nation, Reeves said she was "deeply worried" by Chinese measures and called on the Chinese government "not to put up barriers and limit trade."

She said the action was "bad for the international commerce and creates additional headwinds."

"It is my opinion there are sectors where we must confront Chinese policies, but there are also valuable opportunities to export to China's economy, including banking sector and other areas of the economic system. We've got to maintain that equilibrium appropriate."

The chancellor also affirmed she was cooperating with G7 counterparts "on our own critical minerals strategy, so that we are less reliant."

Health Service Medicine Pricing and Funding

The Chancellor also admitted that the price the NHS pays for pharmaceuticals could go up as a consequence of current talks with the US government and its drugs companies, in exchange for reduced taxes and capital.

Some of the world's largest drug companies have said recently that they are either delaying or abandoning investments in the UK, with several attributing the low prices they are obtaining.

Recently, the government science advisor said the price the NHS pays for medicines would must increase to halt firms and pharmaceutical investment leaving the UK.

The Chancellor stated to media: "We have seen as a result of the payment system, that medical research, new drugs have not been offered in the UK in the extent that they are in other EU nations."

"We want to guarantee that people getting treatment from the NHS are able to access the top critical treatments in the world. And so we are examining this situation, and... seeking to obtain increased funding into the UK."